Abstract
Background Asymptomatic carriage of infected red blood cells (iRBCs) can be prevalent in communities regardless of transmission patterns and can occur with infection of different Plasmodium species. Clinical immunity dampens the inflammatory responses leading to disease symptoms in malaria. The aim of this study was to define the immunological correlates of asymptomatic carriage of P. falciparum in a highly exposed population.
Methods 142 asymptomatic Plasmodium-infected individuals greater than 2 years of age without fever (body temperature <37.5°C) were followed weekly for 10 weeks before being treated with artemisinin-based combination treatment (ACT). Plasma levels of 38 cytokines were measured at baseline by Luminex and the quantity and growth inhibitory activities of circulating parasite-reactive antibodies measured. The Plasmodium antigen tested included P. falciparum merozoite extract (ME) and schizont extract (SE), and the recombinant proteins Erythrocyte binding antigen 175 (EBA-175) and merozoite surface protein 1 (MSP-119).
Results Median levels of IgG against P. falciparum EBA-175 and MSP-119 at baseline were significantly higher in those older than 20 years of age compared with the younger age group and appeared to correlate with better parasite control. Amongst all participants there were no discernible changes in IgG levels over time. Parasite density was higher in the younger age group and associated with IL-10, TNF-α and MCP-1 levels. A balanced IL-10:TNF-α ratio was associated with asymptomatic malaria regardless of age, and balanced ratios of IL-10/TNF-α and IL-10/IFN-γ were the only significant correlate of maintenance of asymptomatic malaria over the course of the study in individuals 20 years of age and younger.
Conclusion The above findings indicate that asymptomatic carriage of P. falciparum in children living in a hyperendemic area occurs independently of IgG but is associated with a balanced inflammatory cytokine ratio.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by a capacity building grant from the Institute Pasteur International Division to Lwarence Ayong.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cameroon National Ethics Committee for Human Health Research (Ethical clearance number 2018/09/1104/CE/CNERSH/SP) ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
All authors declare no conflict of interest in this study.
This work was supported by a capacity building grant from the Institute Pasteur International Division to LSA. This information has previously been presented at the American Association for Tropical Medicine and Hygiene Annual Meeting in 2019.
For analysis of cytokines at the initial time point of our study with respect to correlation with persistent asymptomatic malaria, we employed a mixed linear model using the LME4 package. Cytokine level was used as the response with conversion status as the fixed-effect of the model. We used sex and age as random effects in the model and ran the model separately for children <20 years old, adults >20 years old and all participants, regardless of age. To obtain p-value estimates from the t-values we used the lmerTest package. P values were corrected for multiple comparisons using the Sattherthwaite correction.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
